Flare Therapeutics secured $85 million in an insider-led Series C round.
- Amount
- $85M
- Stage
- Series C
- Announced
- 30 June 2026
- Leads
- Third Rock Ventures, Nextech Invest
- Other investors
- Pfizer Ventures, Boxer Capital, GordonMD Global Investments ® LP, Invus, Casdin Capital, Eli Lilly and Company, Novartis, Agent Capital, Eventide Asset Management
- Use of funds
- Advancing prioritized programs, working capital and general corporate purposes.
- Checked
- Amount and date checked against the press source